IsoRay (ISR) Ships First International GliaSite Orders to Germany

July 11, 2012 7:54 AM EDT Send to a Friend
IsoRay Inc. (AMEX: ISR) announced another step forward in international adoption of its ground-breaking GliaSite radiation therapy system, the world's only liquid radiation balloon catheter device used in the treatment of brain cancers. IsoRay shipped its first orders to Germany as mounting inquiries continue to grow Company confidence in the international market. According to IsoRay CEO Dwight Babcock, "The medical community is clearly becoming aware of the innovative alternative that GliaSite presents as an important advance over previous brain cancer treatments. We are seeing a growth in inquiries from Germany, Italy, Austria, Switzerland, and the United Kingdom."


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Corporate News, FDA

Add Your Comment